These results suggest that inhibiting p-NKCC1 can reduce neuroinflammation in SBI rats, protect BBB, and improve the apoptosis of nerve cells, thereby reducing SBI-induced brain edema and imparting a protective role in the brain. Here, SLC12A2 is linked to brain edema.